Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma

Trial Profile

Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Nilotinib (Primary) ; Vinblastine
  • Indications Glioma
  • Focus Therapeutic Use
  • Acronyms VINILO
  • Sponsors Novartis
  • Most Recent Events

    • 11 Jul 2016 Planned End Date changed from 1 May 2019 to 1 Dec 2020.
    • 11 Jul 2016 Planned primary completion date changed from 1 May 2017 to 1 Dec 2018.
    • 07 Jun 2016 Interim results (n=35) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top